Study found DNA-based screen was more than 90 percent accurate in predicting recurrence
This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.
Risks outweigh benefits for those with few years left, researchers say
Mon Jan 14, 2013 11:14 AM
So bottom line, it is not considered cost effective at older ages. Isn't this the so called Death Panel of that great Obamacare? Risk versus benefit does not even come into this equation. If you read the Obamacare bill, you will find that a panel, not you, not your dr. makes the call on this. It really saddens me to see this website fall for this lie. You are supposed to be helping give GOOD advice, not kowtowing to Obama
We care about your feedback. Let us know how we can improve your CancerCompass experience.